Optimal therapy for multidrug-resistant tuberculosis and HIV

Affiliations

¹ Department of Medicine, Makerere University, Kampala, Uganda. Electronic address: hmk@chs.mak.ac.ug.
² Department of Medicine, Makerere University, Kampala, Uganda.
³ HIV/AIDS and TB Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Comment

Harriet Mayanja-Kizza et al. Lancet. 2020.

. 2020 Aug 8;396(10248):363-365.

doi: 10.1016/S0140-6736(20)31688-3.

¹ Department of Medicine, Makerere University, Kampala, Uganda. Electronic address: hmk@chs.mak.ac.ug.
² Department of Medicine, Makerere University, Kampala, Uganda.
³ HIV/AIDS and TB Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

No abstract available

Comment on

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC, Isaakidis P, Lange C, Menzies D, Migliori GB, Pape JW, Palmero D, Baghaei P, Tabarsi P, Viiklepp P, Vilbrun S, Walsh J, Marks SM. Bisson GP, et al. Lancet. 2020 Aug 8;396(10248):402-411. doi: 10.1016/S0140-6736(20)31316-7. Lancet. 2020. PMID: 32771107 Free PMC article.